128 related articles for article (PubMed ID: 12567595)
1. Effect of 0.2% brimonidine on retinal blood flow.
Yu M; Li Y; Liu X; Ling Y; Zheng X
Yan Ke Xue Bao; 2001 Mar; 17(1):42-5. PubMed ID: 12567595
[TBL] [Abstract][Full Text] [Related]
2. Evaluation and comparison between the effects on intraocular pressure and retinal blood flow of two antiglaucomatous drugs administered in monotherapy: brimonidine and latanoprost. Preliminary results.
Rolle T; Cipullo D; Vizzeri GM; Triggiani A; Brogliatti B
Acta Ophthalmol Scand Suppl; 2000; (232):50-2. PubMed ID: 11235536
[No Abstract] [Full Text] [Related]
3. Comparative analysis of the effects of brimonidine and dorzolamide on ocular blood flow velocity in patients with newly diagnosed primary open-angle glaucoma.
Simsek T; Yanik B; Conkbayir I; Zilelioglu O
J Ocul Pharmacol Ther; 2006 Apr; 22(2):79-85. PubMed ID: 16722793
[TBL] [Abstract][Full Text] [Related]
4. The effect of brimonidine tartrate on retinal blood flow in patients with ocular hypertension.
Carlsson AM; Chauhan BC; Lee AA; LeBlanc RP
Am J Ophthalmol; 2000 Mar; 129(3):297-301. PubMed ID: 10704543
[TBL] [Abstract][Full Text] [Related]
5. The effect of brimonidine tartrate on retinal blood flow in patients with ocular hypertension [corrected].
Carlsson AM; Chauhan BC; Lee AA; Leblanc RP
Am J Ophthalmol; 1999 Dec; 128(6):697-701. PubMed ID: 10612505
[TBL] [Abstract][Full Text] [Related]
6. Effect of brimonidine on retinal blood flow autoregulation in primary open-angle glaucoma.
Feke GT; Hazin R; Grosskreutz CL; Pasquale LR
J Ocul Pharmacol Ther; 2011 Aug; 27(4):347-52. PubMed ID: 21631365
[TBL] [Abstract][Full Text] [Related]
7. Acute and chronic effects of brimonidine 0.2% on intraocular pressure and pulsatile ocular blood flow in patients with primary open-angle glaucoma: an open-label, uncontrolled, prospective study.
Vetrugno M; Maino A; Cantatore F; Ruggeri G; Cardia L
Clin Ther; 2001 Sep; 23(9):1519-28. PubMed ID: 11589264
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of brimonidine 0.2% and timolol 0.5% on retinal nerve fiber layer thickness in ocular hypertensive patients: a prospective, unmasked study.
Tsai JC; Chang HW
J Ocul Pharmacol Ther; 2005 Dec; 21(6):475-82. PubMed ID: 16386089
[TBL] [Abstract][Full Text] [Related]
9. Ocular perfusion pressure and visual field indice modifications induced by alpha-agonist compound (clonidine 0.125%, apraclonidine 1.0% and brimonidine 0.2%) topical administration. An acute study on primary open-angle glaucoma patients.
Costagliola C; Parmeggiani F; Ciancaglini M; D'Oronzo E; Mastropasqua L; Sebastiani A
Ophthalmologica; 2003; 217(1):39-44. PubMed ID: 12566871
[TBL] [Abstract][Full Text] [Related]
10. [The ocular hypotensive effect and safety of 0.2% brimonidine].
Yu M; Li Y; Ge J
Yan Ke Xue Bao; 2001 Dec; 17(4):235-8. PubMed ID: 12567513
[TBL] [Abstract][Full Text] [Related]
11. Effect of brimonidine tartrate on ocular hemodynamic measurements.
Lachkar Y; Migdal C; Dhanjil S
Arch Ophthalmol; 1998 Dec; 116(12):1591-4. PubMed ID: 9869786
[TBL] [Abstract][Full Text] [Related]
12. Effects of brimonidine 0.2% on blue-yellow perimetry of glaucomatous patients.
Mastropasqua L; Ciancaglini M; Carpineto P; Zuppardi E; Falconio G; Gallenga PE
Acta Ophthalmol Scand Suppl; 1998; (227):36. PubMed ID: 9972338
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic success of latanoprost 0.005% compared to brimonidine 0.2% in patients with open-angle glaucoma or ocular hypertension.
Stewart WC; Day DG; Stewart JA; Holmes KT; Leech JN; Rowan CT; Schwartz GF
J Ocul Pharmacol Ther; 2000 Dec; 16(6):557-64. PubMed ID: 11132902
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension.
Stewart WC; Sharpe ED; Day DG; Kolker AE; Konstas AG; Lee WH; Rieser JC; Chopra H; Holmes KT
J Ocul Pharmacol Ther; 2000 Jun; 16(3):251-9. PubMed ID: 10872922
[TBL] [Abstract][Full Text] [Related]
15. Short posterior ciliary artery, central retinal artery, and choroidal hemodynamics in brimonidine-treated primary open-angle glaucoma patients.
Schmidt KG; Klingmüller V; Gouveia SM; Osborne NN; Pillunat LE
Am J Ophthalmol; 2003 Dec; 136(6):1038-48. PubMed ID: 14644214
[TBL] [Abstract][Full Text] [Related]
16. [Clinical efficacy of 0.2% brimonidine in patients with open-angle glaucoma or ocular hypertension].
Shi JM; Jiang YQ
Hunan Yi Ke Da Xue Xue Bao; 2002 Jun; 27(3):263-6. PubMed ID: 12575311
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness and safety of brimonidine as mono-, combination, or replacement therapy for patients with primary open-angle glaucoma or ocular hypertension: a post hoc analysis of an open-label community trial. Glaucoma Trial Study Group.
Lee DA; Gornbein J; Abrams C
J Ocul Pharmacol Ther; 2000 Feb; 16(1):3-18. PubMed ID: 10673126
[TBL] [Abstract][Full Text] [Related]
18. A double-masked randomized crossover study comparing the effect of latanoprost/timolol and brimonidine/timolol fixed combination on intraocular pressure and ocular blood flow in patients with primary open-angle glaucoma or ocular hypertension.
Hommer A; Sperl P; Resch H; Popa-Cherecheanu A; Qiao C; Schmetterer L; Garhöfer G
J Ocul Pharmacol Ther; 2012 Dec; 28(6):569-75. PubMed ID: 22775229
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of brimonidine treatment in a rodent model of ischemic optic neuropathy.
Danylkova NO; Alcala SR; Pomeranz HD; McLoon LK
Exp Eye Res; 2007 Feb; 84(2):293-301. PubMed ID: 17113077
[TBL] [Abstract][Full Text] [Related]
20. Contrast sensitivity improves after brimonidine therapy in primary open angle glaucoma: a case for neuroprotection.
Evans DW; Hosking SL; Gherghel D; Bartlett JD
Br J Ophthalmol; 2003 Dec; 87(12):1463-5. PubMed ID: 14660453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
